Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergey Shcherbinin

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
European Journal of Nuclear Medicine and Molecular Imaging|April 5, 2023
Longitudinal head-to-head comparison of <sup>11</sup>C-PiB and <sup>18</sup>F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer's diseaseCharles D Chen, Austin McCullough, Brian Gordon, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
Novel <i>CYP1B1-RMDN2</i> Alzheimer's disease locus identified by genome-wide association analysis of cerebral tau deposition on PETKwangsik Nho, Shannon L Risacher, Liana Apostolova, et al.
Nature Communications|September 20, 2024
CYP1B1-RMDN2 Alzheimer's disease endophenotype locus identified for cerebral tau PETKwangsik Nho, Shannon L Risacher, Liana G Apostolova, et al.
Nature Neuroscience|July 16, 2025
Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-β status, APOE genotype and sexRik Ossenkoppele, Emma M Coomans, Liana G Apostolova, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
European Journal of Nuclear Medicine and Molecular Imaging|April 5, 2023
Longitudinal head-to-head comparison of <sup>11</sup>C-PiB and <sup>18</sup>F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer's diseaseCharles D Chen, Austin McCullough, Brian Gordon, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
Novel <i>CYP1B1-RMDN2</i> Alzheimer's disease locus identified by genome-wide association analysis of cerebral tau deposition on PETKwangsik Nho, Shannon L Risacher, Liana Apostolova, et al.
Nature Communications|September 20, 2024
CYP1B1-RMDN2 Alzheimer's disease endophenotype locus identified for cerebral tau PETKwangsik Nho, Shannon L Risacher, Liana G Apostolova, et al.
Nature Neuroscience|July 16, 2025
Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-β status, APOE genotype and sexRik Ossenkoppele, Emma M Coomans, Liana G Apostolova, et al.
Pageof 8